Regarded as one of the world’s leading regulatory bodies, Swissmedic stands alongside its equivalents in Europe, Japan, Canada, and Australia in terms of the evaluation and approval of new drugs. Although its approval times are increasing, raising doubts about Swissmedic’s continued place at the top table of global regulators, initiatives to address this issue are being rolled out and the organisation is also looking towards international collaboration to bolster its standing. See below for the new medicines Swissmedic approved in 2020.
written on 18.02.2021
Swissmedic New Drug Approvals 2020
Similar Facts and Figures
Data / Switzerland Innovation & Competitiveness Snapshot 2020
In just a few years, Switzerland has fallen from first to fifth place in the Global Competitiveness Index. The…